Smith Robin L 4
4 · Sorrento Therapeutics, Inc. · Filed Sep 3, 2021
Insider Transaction Report
Form 4
Smith Robin L
Director
Transactions
- Exercise/Conversion
Common Stock
2021-09-03$4.89/sh+100,000$489,000→ 235,000 total - Exercise/Conversion
Stock Options
2021-09-03−75,000→ 0 totalExercise: $3.95Exp: 2029-12-16→ Common Stock (75,000 underlying) - Exercise/Conversion
Common Stock
2021-09-03$3.95/sh+75,000$296,250→ 135,000 total - Exercise/Conversion
Stock Options
2021-09-03−100,000→ 0 totalExercise: $4.89Exp: 2030-06-15→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]1/12 of the original number of shares subject to this option vested and became exercisable on January 16, 2020 and 1/12 of the original number of shares subject to the option vested following each one month of service thereafter.
- [F2]1/12 of the original number of shares subject to this option vested and became exercisable on July 15, 2020 and 1/12 of the original number of shares subject to the option vested following each one month of service thereafter.